MARKET

MRNA

MRNA

Moderna
NASDAQ
38.80
-3.20
-7.61%
Opening 11:50 02/11 EST
OPEN
37.71
PREV CLOSE
42.00
HIGH
38.95
LOW
36.66
VOLUME
8.28M
TURNOVER
--
52 WEEK HIGH
55.20
52 WEEK LOW
22.28
MARKET CAP
15.16B
P/E (TTM)
-4.8207
1D
5D
1M
3M
1Y
5Y
1D
FDA’s vaccines chief reportedly overrules staffers to reject Moderna’s flu shot application
Seeking Alpha · 1h ago
Prasad overruled FDA scientists on Moderna application, STAT says
TipRanks · 1h ago
BUZZ-U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec
Reuters · 1h ago
These Stocks Are Today's Movers: Shopify, Moderna, Robinhood, Vertiv, Unity, Zillow, Beta Tech, Lyft, Mattel, Astera, and More
Barron‘s · 1h ago
'The unusual Prasad missive in the FDA's rejection of the Moderna flu shot application'- STAT News
Benzinga · 1h ago
FDA'S VINAY PRASAD OVERRULED STAFF TO REJECT MODERNA’S FLU VACCINE APPLICATION - STAT NEWS
Reuters · 2h ago
U.S. stocks seesaw as the nonfarm payrolls shocks the markets
Seeking Alpha · 2h ago
Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB
The Wall Street Journal · 2h ago
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.